Descrizione Azione

A synthesized peptide derived from Human alpha 2b Adrenergic Receptor.

Codice: BF8593 Confezionamento: 100ul
Dettagli

A synthesized peptide derived from human alpha 2 Macroglobulin/A2M, corresponding to a region within the internal amino acids.

Codice: DF8174 Confezionamento: 100ul
Dettagli

A synthesized peptide derived from human alpha 2 Macroglobulin/A2M, corresponding to a region within the internal amino acids.

Codice: DF6469 Confezionamento: 100ul
Dettagli

A synthesized peptide derived from Human alpha 5 Defensin.

Codice: DF14360 Confezionamento: 100ul
Dettagli

A synthetic peptide from human alpha 5 Defensin

Codice: BF4161
Dettagli

A synthesized peptide derived from human alpha-Actinin, corresponding to a region within N-terminal amino acids.

Codice: DF6294 Confezionamento: 100ul
Dettagli

A synthesized peptide derived from human alpha-Actinin, corresponding to a region within the internal amino acids.

Codice: AF4629 Confezionamento: 50ul
Dettagli

A synthesized peptide derived from human alpha-Actinin, corresponding to a region within the internal amino acids.

Codice: BF8341 Confezionamento: 50ul
Dettagli

A synthetic peptide from human alpha-Actinin

Codice: BF3838 Confezionamento: 100ul
Dettagli

A synthesized peptide derived from human alpha Adaptin, corresponding to a region within the internal amino acids.

Codice: DF12347 Confezionamento: 100ul
Dettagli

α-Amylase in human body can not only act on the end of starch, but also act on the α-1,4 glucoside bond inside starch molecules. The degradation products are glucose, maltose and dextrin containing α-1,6 glucoside bond branch chain, which plays an important role in the digestion of polysaccharide compounds in food. Inhibition of α-amylase activity can not only reduce the digestion and absorption of starch, but also allow undigested and absorbed starch to enter the large intestine, promote gastrointestinal motility, and further reduce the occurrence of type 2 diabetes, which is an important drug target for the treatment of diabetes. The detection principle of this kit: α-Amylase catalyzes the substrate reaction to generate colored products, whose absorbance increases at 405 nm. The addition of an inhibitor suppresses the activity of α-Amylase, resulting in a reduced rate of absorbance increase. The inhibition rate can be calculated based on the absorbance difference.

Codice: E-BC-D018_48T Confezionamento: 48T
Dettagli

α-Amylase in human body can not only act on the end of starch, but also act on the α-1,4 glucoside bond inside starch molecules. The degradation products are glucose, maltose and dextrin containing α-1,6 glucoside bond branch chain, which plays an important role in the digestion of polysaccharide compounds in food. Inhibition of α-amylase activity can not only reduce the digestion and absorption of starch, but also allow undigested and absorbed starch to enter the large intestine, promote gastrointestinal motility, and further reduce the occurrence of type 2 diabetes, which is an important drug target for the treatment of diabetes. The detection principle of this kit: α-Amylase catalyzes the substrate reaction to generate colored products, whose absorbance increases at 405 nm. The addition of an inhibitor suppresses the activity of α-Amylase, resulting in a reduced rate of absorbance increase. The inhibition rate can be calculated based on the absorbance difference.

Codice: E-BC-D018_96T Confezionamento: 96T
Dettagli